Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Schroll Medical ApS
APS
Active
Advertising protection
CVR 39467135
Kirstinebjergvej 33, 5792
Årslev
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2018 · 8 years old
123 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Schroll Medical ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
CG
Carsten Garbo Schroll
Chief Executive Officer
Chief Executive Officer
2026
Former (1)
FH
Frederik Harald Halberg
Chief Executive Officer
Chief Executive Officer
2025 – 2026
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
MP
Mariolla Pernille Damborg Dolleris Schroll
Board of Directors
Board of Directors
2025
SD
Søren Dolleris Schroll
Chairman
Chairman
2026
SG
Stine Garbo Schroll
Board of Directors
Board of Directors
2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Schroll Medical Holding ApS
Company
100%
100%
2025
Nuuvera Holdings Limited
Individual
5–9.99%
5–9.99%
2021
Schroll Medical Holding ApS
Company
100%
100%
2024
Nuuvera Holdings Li,ited
Individual
10–14.99%
10%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Schroll Medical ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network